From laboratory to point of care: Clinical performance and validation of bSens.INR for prothrombin time and INR monitoring

Background

Anticoagulant therapy with vitamin K antagonists, particularly warfarin, requires periodic monitoring of prothrombin time (PT) and the International Normalized Ratio (INR) to maintain patients within the therapeutic range and reduce thromboembolic and hemorrhagic risks. Point-of-care (POC) devices may improve the accessibility and frequency of anticoagulation monitoring.